“Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01% Tazarotene 0.045% (HP TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis”. 2020. SKIN The Journal of Cutaneous Medicine 4 (1): S9. https://skin.dermsquared.com/skin/article/view/822.